DE   EN   ES   FR   IT   PT


medicalmeds.eu Medicines MIBP-vaccine. Vaccine meningococcal groups A polisakharidny

Vaccine meningococcal groups A polisakharidny

Препарат Вакцина менингококковая группы А полисахаридная. ФГУП НПО «Микроген» Россия


Producer: Federal state unitary enterprise NPO Mikrogen Russia

Code of automatic telephone exchange: J07AH01

Release form: Liquid dosage forms. Lyophilisate for preparation of solution for hypodermic introduction.

Indications to use: Prevention of a meningococcal infection.


General characteristics. Structure:

Active ingredient: 250 mkg of the cleared A serogroup Neisseria meningitidis polysaccharides.

Excipients: 0,9% solution of sodium chloride.




Pharmacological properties:

Pharmacodynamics. Causes increase of specific antibodies to Neisseria meningitidis of serogroups A, C, W135 and Y.

Polisakharidny vaccine for prevention of a meningococcal infection of serogroups And yes S. Formiruyet active specific immunity to meningokokka (Neisseria meningitidis) of serogroups And yes Page. Does not provide protection against purulent meningitis of other etiology (including meningokokk of group B, Haemophilus influenzae, Streptococcus pneumoniae, etc.).


Immunity remains within 3 years after vaccination.


Indications to use:

Prevention of the meningococcal infection caused by meningokokka of groups A and C in children and adults.


Route of administration and doses:

Single vaccination since 18-month age in 1 dose irrespective of age. The vaccine is entered п / to or in oil.


Features of use:

Use at pregnancy. Pregnancy and a lactation are not a contraindication in adverse epidemic situations.

Special instructions. Vaccination children aged up to 18 months are not subject, excepting epidemic situations since on a vaccine component A immunity can develop from 3 months, and on a component C - practically does not develop.


Side effects:

Very seldom: (it is more probable at adults) in the first 72 h after introduction - insignificant fever, a fever, weakness; insignificant and short erubescence and morbidity in a vaccine injection site.



Contraindications:

Acute and chronic diseases.



Storage conditions:

Vaccine period of validity - 3 years. Drug is not subject to expired use. At a temperature from 2 °C to 8 °C according to the joint venture 3.3.2.1248-03. To store in the place, unavailable to children. Freezing is not allowed. Transportation conditions. At a temperature from 2 °C to 8 °C According to the joint venture 3.3.2.1248-03. Freezing is not allowed.


Issue conditions:

According to the recipe


Packaging:

1 amp. (5 doses) - ampoules (5) complete with solvent (5 amp. on 5 ml) - packs cardboard.



Similar drugs

Препарат Менцевакс ACWY. ФГУП НПО «Микроген» Россия

Менцевакс ACWY

Vaccine for prevention of the diseases caused by meningokokka.





  • Сайт детского здоровья